EUCTR2011-004616-36-SE进行中（未招募）1 期
A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD) - EUCLID
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 13,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male and Female patients 50 years old or older
- •2. Symptomatic peripheral artery disease
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5400
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 8100
排除标准
- •1. Patients needing dual anti-platlet drug treatment before start of study
- •2. Planned revascularisation or amputation
- •3. Patients with known bleeding disorders
- •4. Patients with a history of intracranial bleed
- •5. Patients considered to be at risk of bradycardic events unless already treated with a permanent pacemaker
研究者
相似试验
进行中（未招募）
1 期
A study comparing cardiovascular effects of ticagrelor and clopidogrel in patients with Peripheral Artery DiseaseEUCTR2011-004616-36-HUAstraZeneca AB13,500
进行中（未招募）
1 期
A study to evaluate the safety and efficacy of fluticasone furoate/vilanterol combination compared to fluticasone furoate in the treatment of asthma in participants (aged 5 to 17 years old inclusive).MedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2016-004086-87-LTGlaxoSmithKline Research & Development Limited870
进行中（未招募）
1 期
A study comparing cardiovascular effects of ticagrelor and clopidogrel in patients with Peripheral Artery Diseaseperipheral artery diseaseMedDRA version: 18.1Level: LLTClassification code 10067825Term: Peripheral arterial diseaseSystem Organ Class: 100000004866EUCTR2011-004616-36-SKAstraZeneca AB13,500
已完成
3 期
A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)NL-OMON41255Astra Zeneca225
进行中（未招募）
1 期
A study comparing cardiovascular effects of ticagrelor and clopidogrel in patients with Peripheral Artery Diseaseperipheral artery diseaseMedDRA version: 17.1Level: LLTClassification code 10067825Term: Peripheral arterial diseaseSystem Organ Class: 100000004866EUCTR2011-004616-36-DEAstraZeneca AB13,500